What Are the Key Gut Microbiota Involved in Neurological Diseases? A Systematic Review

被引:38
作者
Bonnechere, Bruno [1 ,2 ]
Amin, Najaf [2 ]
van Duijn, Cornelia [2 ]
机构
[1] Hasselt Univ, Fac Rehabil Sci, REVAL Rehabil Res Ctr, B-3590 Diepenbeek, Belgium
[2] Univ Oxford, Nuffield Dept Populat Hlth, Oxford OX3 7LF, England
关键词
gut microbiome; Parkinson's disease; Alzheimer's disease; stroke; multiple sclerosis; atrophic lateral sclerosis; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; INTESTINAL MICROBIOTA; MOTOR DEFICITS; BRAIN; DIET; NEUROINFLAMMATION; ASSOCIATION; PROBIOTICS; DYSBIOSIS;
D O I
10.3390/ijms232213665
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is a growing body of evidence highlighting there are significant changes in the gut microbiota composition and relative abundance in various neurological disorders. We performed a systematic review of the different microbiota altered in a wide range of neurological disorders (Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS), amyotrophic lateral sclerosis, and stroke). Fifty-two studies were included representing 5496 patients. At the genus level, the most frequently involved microbiota are Akkermansia, Faecalibacterium, and Prevotella. The overlap between the pathologies was strongest for MS and PD, sharing eight genera (Akkermansia, Butyricicoccus, Bifidobacterium, Coprococcus, Dorea, Faecalibacterium, Parabacteroides, and Prevotella) and PD and stroke, sharing six genera (Enterococcus, Faecalibacterium, Lactobacillus, Parabacteroides, Prevotella, and Roseburia). The identification signatures overlapping for AD, PD, and MS raise the question of whether these reflect a common etiology or rather common consequence of these diseases. The interpretation is hampered by the low number and low power for AD, ALS, and stroke with ample opportunity for false positive and false negative findings.
引用
收藏
页数:24
相关论文
共 196 条
[1]   Microbiome-microglia connections via the gut-brain axis [J].
Abdel-Haq, Reem ;
Schlachetzki, Johannes C. M. ;
Glass, Christopher K. ;
Mazmanian, Sarkis K. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2019, 216 (01) :41-59
[2]   Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression [J].
Aho, Velma T. E. ;
Pereira, Pedro A. B. ;
Voutilainen, Sari ;
Paulin, Lars ;
Pekkonen, Eero ;
Auvinen, Petri ;
Scheperjans, Filip .
EBIOMEDICINE, 2019, 44 :691-707
[3]   Antibiotics, gut microbiota, and Alzheimer's disease [J].
Angelucci, Francesco ;
Cechova, Katerina ;
Amlerova, Jana ;
Hort, Jakub .
JOURNAL OF NEUROINFLAMMATION, 2019, 16 (1)
[4]   Altered profile of human gut microbiome is associated with cirrhosis and its complications [J].
Bajaj, Jasmohan S. ;
Heuman, Douglas M. ;
Hylemon, Phillip B. ;
Sanyal, Arun J. ;
White, Melanie B. ;
Monteith, Pamela ;
Noble, Nicole A. ;
Unser, Ariel B. ;
Daita, Kalyani ;
Fisher, Andmorgan R. ;
Sikaroodi, Masoumeh ;
Gillevet, Patrick M. .
JOURNAL OF HEPATOLOGY, 2014, 60 (05) :940-947
[5]   Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation [J].
Bajaj, Jasmohan S. ;
Hylemon, Phillip B. ;
Ridlon, Jason M. ;
Heuman, Douglas M. ;
Daita, Kalyani ;
White, Melanie B. ;
Monteith, Pamela ;
Noble, Nicole A. ;
Sikaroodi, Masoumeh ;
Gillevet, Patrick M. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2012, 303 (06) :G675-G685
[6]   Novel Mechanisms and Therapeutic Targets for Ischemic Stroke: A Focus on Gut Microbiota [J].
Bao, Zeyu ;
Zhang, Zeyu ;
Zhou, Guoyang ;
Zhang, Anke ;
Shao, Anwen ;
Zhou, Feng .
FRONTIERS IN CELLULAR NEUROSCIENCE, 2022, 16
[7]   Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism [J].
Barichella, Michela ;
Severgnini, Marco ;
Cilia, Roberto ;
Cassani, Erica ;
Bolliri, Carlotta ;
Caronni, Serena ;
Ferri, Valentina ;
Cancello, Raffaella ;
Ceccarani, Camilla ;
Faierman, Samanta ;
Pinelli, Giovanna ;
De Bellis, Gianluca ;
Zecca, Luigi ;
Cereda, Emanuele ;
Consolandi, Clarissa ;
Pezzoli, Gianni .
MOVEMENT DISORDERS, 2019, 34 (03) :396-405
[8]   Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson's disease patients [J].
Bedarf, J. R. ;
Hildebrand, F. ;
Coelho, L. P. ;
Sunagawa, S. ;
Bahram, M. ;
Goeser, F. ;
Bork, P. ;
Wuellner, U. .
GENOME MEDICINE, 2017, 9
[9]  
Bibbò S, 2016, EUR REV MED PHARMACO, V20, P4742
[10]   The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS) [J].
Boddy, Sarah L. ;
Giovannelli, Ilaria ;
Sassani, Matilde ;
Cooper-Knock, Johnathan ;
Snyder, Michael P. ;
Segal, Eran ;
Elinav, Eran ;
Barker, Lynne A. ;
Shaw, Pamela J. ;
McDermott, Christopher J. .
BMC MEDICINE, 2021, 19 (01)